Surgery. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males

By Bouloux P.M.G.   Handelsman D.J.   Jockenhövel F.   Nieschlag E.   Rabinovici J.   Frasa W.L.H.   de Bie J.J.   Voortman G.   Voortman J.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2727-2727

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)

By Lenton E.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1021-1027

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle

By Zariñán T.  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1611-1618

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

By Daya S.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2563-2569

Oxford University Press

Access to resources Recommend Favorite

Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females

By Duijkers Ingrid J.M.  

Human Reproduction, Vol. 17, Iss. 8, 2002-08 ,pp. : 1987-1993

Oxford University Press

Access to resources Recommend Favorite